
Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide …

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …

Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …

The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …

A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …

Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination …

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …

An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …